Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD).

Rodriguez, Francisco D; Coveñas, Rafael

Rodriguez, Francisco D; Coveñas, Rafael.

Affiliation

Rodriguez FD; Department of Biochemistry and Molecular Biology, Group GIR-BMD, Faculty of Chemistry, University of Salamanca, 37001 Salamanca. Spain.
Coveñas R; Institute of Neurosciences of Castilla y León (INCYL), Laboratory of Neuroanatomy of the Peptidergic Systems, University of Salamanca, 37007 Salamanca. Spain.

Curr Med Chem ; 24(23): 2528-2558, 2017.

Article in En | MEDLINE | ID: mdl-28302012

Subject(s)

Alcohol Drinking/drug therapy; Alcohol-Related Disorders/drug therapy; Corticotropin-Releasing Hormone/antagonists & inhibitors; Neuropeptide Y/antagonists & inhibitors; Neuropeptides/antagonists & inhibitors; Urocortins/antagonists & inhibitors; Alcohol Drinking/metabolism; Alcohol-Related Disorders/metabolism; Animals; Corticotropin-Releasing Hormone/metabolism; Humans; Neuropeptide Y/metabolism; Neuropeptides/metabolism; Urocortins/metabolism

Key words

Alcohol use disorder (AUD); alcoholism; corticotropin- releasing factor (CRF); neuropeptide S (NPS); neuropeptide Y; neuropeptide antagonists; urocortin I

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuropeptide Y / Neuropeptides / Alcohol Drinking / Corticotropin-Releasing Hormone / Alcohol-Related Disorders / Urocortins Limits: Animals / Humans Language: En Journal: Curr Med Chem Journal subject: QUIMICA Year: 2017 Document type: Article Country of publication: United Arab Emirates

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google